Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identification of a JAK/STAT/miR155HG positive feedback loop in regulating NK cell proliferation and effector functions

ABSTRACT: The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway control NK cell development, expansion and cytotoxic functions. Whether lncRNA regulates the JAK-STAT signaling in NK cells remains unknown. We found that miR155HG was upregulated in activated NK cells and promoted their proliferation and effector functions. Mechanistically, miR155HG bound to miR-6756 and relieved its repression of JAK3 expression, resulting in increased JAK3 level and enhanced NK cells proliferation and function. Further investigations disclosed that upon cytokine stimulation, STAT3 directly interacts with miR155HG promoter and induces miR155HG transcription. Collectively, we identify a miR155HG-mediated positive feedback loop of the JAK-STAT signaling. In brief, STAT3 interacts with miR155HG promoter and induces miR155HG transcription upon cytokine stimulation, and miR155HG may work as a sponge for miR-6756, preventing the miR-6756-mediated repression of JAK3 expression, thereby promoting the JAK-STAT pathway and enhancing NK cell proliferation and function. These findings may provide a promising therapeutic target to improve NK cell therapy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE277650 | GEO | 2025/12/21

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Effect of a JAK inhibitor on gene expression of HUT78 cell line

Project description:Developing targeted therapy for cutaneous T cell lymphoma (CTCL) patients still requires actionable mutated genes and deregulated pathways to be identified. There is increasing evidence that activating mutations in JAK genes and deregulated JAK/STAT signaling are important mechanisms involved in multiple B and T cell malignancies, including CTCL. Therefore, in this study we focused on studying the mutational status of JAK1, JAK2 and JAK3 genes in a series of human CTCL lesions and cell lines using next-generation sequencing (NGS). We found that 7 of 48 (14.7%) of the analyzed cases harbored mutations in the JAK1 and JAK3 genes that mainly affected the pseudokinase domain of the corresponding proteins. On the basis of these results, we used a specific JAK inhibitor (INCB018424) in a series of CTCL cell lines with deregulated JAK/STAT activity. Treatment of CTCL cells with INCB018424 resulted in dose-dependent reduction of activated STAT expression, diminished cell viability, and increased apoptosis. We also studied global changes in gene expression in cells with mutated JAK1 and JAK3 proteins treated with INCB018424 and identified multiple genes that were differentially regulated by JAK/STAT signaling, such as FGF20 (upregulated) and EGR1 (downregulated). Thus, our results show that the detection of deregulated JAK/STAT signaling in CTCL lesions via JAK mutations or other surrogate markers may serve to indicate the clinical use of JAK/STAT inhibitors. 3 replicates of cells treated with DMSO or JAKi during 30 min and 3h

2015-10-31 | E-GEOD-68562 | biostudies-arrayexpress

Transcription profiling of human Sez-4 cell line starved of IL2 for 16h, followed by addition of IL-2 activation and or JAK inhibition

Project description:In this study we compared the effects of IL-2, IL-15, and IL-21 on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from the CD4+ cutaneous T-cell lymphoma (CTCL). Whereas both IL-2 and IL-15 that signal through receptors that share the common gamma chain and the beta chain modulated the expression of >1,000 genes, IL-21 that signals via the receptor also containing gamma chain up-regulated <40 genes. All three cytokines induced tyrosine phosphorylation of Jak1 and Jak3. However, only IL-2 and IL-15 strongly activated STAT5, PI3K/Akt, and MEK/ERK signaling pathways. In contrast, IL-21 selectively activated STAT3. Whereas all three cytokines protected CTCL cells from apoptosis, only IL-2 and IL-15 promoted their proliferation. The effects of the cytokine stimulation were Jak3- and Jak1-kinase dependent. These findings document the vastly different impact of IL-2 and IL-15 vs. IL-21 on malignant CD4+ T cells. They also suggest two novel therapeutic approaches to CTCL and, possibly, other CD4+ T cell lymphomas: inhibition of the Jak1/Jak3 kinase complex and, given the known strong immunostimulatory properties of IL-21 on CD8+ T, NK, and B cells, application of this cytokine to boost an immune response against malignant CD4+ T cells. Experiment Overall Design: Sez-4 cell line was starved of IL-2 for 16h, washed twice and placed into 6-well plates in 10ml RPMI (10% FBS) for 2h followed by pre-treating for 30â?? with pan-Jak inhibitor (300 nM), Jak3 inhibitor (300 nM), or drig solvent and cultured with IL-2 (200U) or medium alone for 4 h.

2008-04-09 | E-GEOD-8687 | biostudies-arrayexpress

Effect of a JAK inhibitor on gene expression of HUT78 cell line

2015-10-31 | GSE68562 | GEO

microRNA-21 deletion impairs regulatory T cell function

Project description:Background: It has been found that miR-21 is increased in colonic tissues and decreased in peripheral blood regulatory T cells (Tregs) of patients with ulcerative colitis (UC). We aimed to investigate the influence of miR-21 on Tregs function in intestinal inflammation. Methods: Various CD4+ T cell populations were flow-cytometry sorted from miR-21-/- mice and littermates (WT) utilization in T-cell transfer colitis model and suppression of T cell activation and proliferation by Tregs. Gene expression was microarray-profiled and validated by qPCR, ELISA and immunofluorescence. miR-21 mimic and inhibitor studies and a 3’-untranslated region of SOCS5 luciferase report assay were used to validate the effect of miR-21. Results: As compared to their littermates, miR-21-/- mice have less Tregs in lymph nodes. miR-21-/- Tregs produced higher amount of SOCS5 and IFNγ, and lower amount of Jak3, Stat3, Stat5a, Foxp3, TGFβ1 and IL10. miR-21-/- Tregs reduced suppressive function in vitro and in vivo. Functional assays indicated that miR-21 could directly suppress SOCS5 expression. Conclusions: Expression and function of miR-21 are cell-type- and context- dependent. miR-21 deficiency result in impaired SOCS-JAK-STAT pathway activity in Tregs. miR-21 play a positive role in Tregs differentiation and suppressive function.

2017-09-29 | GSE104363 | GEO

Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia

Project description:T-prolymphocytic leukemia (T-PLL) is a rare, aggressive T-cell malignancy with poor outcomes and an urgent need for new therapeutic approaches. Integrating genomic data and new transcriptomic profiling, we identified recurrent JAK/STAT mutations as a hallmark in T-PLL in an unprecedented cohort of 335 T-PLL cases, predominantly involving JAK3 and STAT5B. In line, transcriptomic and immunoblot analyses revealed constitutive JAK/STAT activation in virtually all samples. Building on these findings, we explored the therapeutic potential of dual STAT3/STAT5 non-PROTAC degraders in T-PLL treatment, with JPX-1244 as our lead substance. JPX-1244 efficiently and selectively induced cell death in primary T-PLL samples, including those resistant to conventional therapies, by blocking STAT3/STAT5 phosphorylation and inducing their degradation. The extent of STAT3/STAT5 degradation directly correlated with cytotoxicity. RNA-sequencing confirmed the downregulation of STAT5 target genes. While JAK/STAT mutations did not predict treatment responses, elevated TOX, PAK6, and SPINT1 expression was associated with drug sensitivity. In a subsequent combination screening, cladribine, venetoclax, and azacytidine emerged as most effective combination partners even in low-responding T-PLL samples, synergistically reducing STAT5 phosphorylation. These findings highlight dual STAT3/STAT5 inhibition, particularly in combination with hypomethylating agents, as a promising therapeutic approach in T-PLL, warranting further preclinical and clinical investigation.

2025-06-16 | GSE286270 | GEO

EGF activation of POMC gene transcription is mediated by STAT3

Project description:Classical activation of the hypothalamic-pituitary-adrenal axis (HPA) is exerted by stimulation of pituitary POMC gene transcription and ACTH release by the hypothalamic hormone CRH. In parallel, inflammatory cytokines such as IL6 and LIF also stimulate ACTH release and POMC transcription through the JAK/STAT pathway. In recent years, a particular interest in the role of the EGF pathway for POMC activation was sparked by the identification of causative mutations in the USP8 gene that have been implicated in formation of pituitary corticotrope adenomas that are the hallmark of Cushing’s disease. These mutations were associated with persistent upregulation of the EGF/EGFR pathway and its putative role in ACTH hypersecretion. In the present work, we reassessed the signalling pathways that are activated in response to ACTH in pituitary corticotrope cells using the AtT-20 cell model. We confirmed activation of the MAP kinase pathway by EGF but also show activation of the AKT/mTOR and JAK/STAT pathways. Whereas activation of all three pathways appears essential for stimulation of cell proliferation, only the JAK/STAT pathway and more specifically STAT3, enhances POMC gene transcription. This action is mapped to a single STAT binding element of the POMC promoter in contrast to activation by the other STAT-activating cytokines LIF and IL6. Further, EGF signalling is specifically enhanced by STAT3 but not STAT1 in contrast to LIF-dependent activation. All together, the data identified a unique STAT3-dependent target on the POMC promoter that mediates EGF activation of POMC gene transcription.

2025-11-03 | GSE292424 | GEO

Effect of JAK1/3 blockade on IL2 response in NK cells

2016-07-20 | GSE84562 | GEO

Effect of JAK1/3 blockade on IL2 response in NK cells

Project description:IL2 signals are transmitted through JAK1 and JAK3, but the transcriptomic consequences of each to the overall response is unclear. Here we analyzed the relative contribution of JAK1 and JAK3 to the NK cell IL2 response in vitro using titrated doses of isoform specific JAK inhibitors. Blockade of JAK1 and JAK3 have unequal effects on IL2-induced transcripts at pharmacologically relevant doses. Splenic NK cells were isolated by negative selection from 6wk old male C57BL/6 mice. These were cultured with IL2 (250U/ml) in the presence or absence of JAK1/3 inhibitors for 8hrs in vitro. Cells were then transferred directly into TriZol. RNA was prepared in Trizol for gene expression profiling by Affymetrix Mouse Gene 1.0 ST Arrays.

2016-07-20 | E-GEOD-84562 | biostudies-arrayexpress

Targeting synergetic endothelial inflammation by inhibiting NFKB and JAK-STAT pathways

Project description:Multiple systemic vascular inflammatory disorders are associated with endothelial dysfunction and elevated levels of TNFα and IFNγ. Combined TNFα and IFNγ stimulation induces synergetic hyperinflammation in endothelial cells (ECs) through activation of the NFKB and JAK/STAT pathways. Here we assess how targeting these pathways affects EC inflammation. Using mass-spectrometry based proteomics, we investigate system-wide effects of TNFα- and IFNγ-stimulated Endothelial Colony Forming Cells (ECFCs) in combination with inhibitors targeting NFKB and JAK/STAT pathways. JAK1 inhibitor itacitinib blocked IFNγ-, but not TNFα-induced proteomic responses. IKK2/STAT3 inhibitor TPCA1 attenuated both responses. Most TNFα+IFNγ-induced proteins, such as pyroptosis mediators, chemokines and Weibel-Palade Body content, were inhibited by both inhibitors, highlighting their synergetic dependency on both pathways. Imaging of Von Willebrand Factor (VWF) revealed an extracellular VWF network induced by combined stimulation; a phenotype which was reverted by both inhibitors. This study provides a mechanistic basis for inhibiting endothelial inflammation in vascular inflammatory disorders.

2025-07-17 | PXD064921 | Pride

Genome-wide binding signature of Signal transducer and activator of transcription (STAT) family in colorectal cancer HCT 116 cell

Project description:The excessive and continuous activated Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway leads to the proliferation and migration of malignant cells resulting in the occurrence and development of almost all of cancers. The defined gene sets specifically activated by different STAT proteins are relied on their genomic accessibility by the interplay of certain STAT proteins with other potential cofactors. However, we have no clue about the status of human activated STAT dimers in the nucleus, as well as the intercrossing modules of synergic, supplementary or competitive relationship among each other in colorectal cancer. In current study, chromatin immunoprecipitation sequencing (ChIP-seq) was conducted to explore the genome-scale binding signatures of STAT1, STAT2, STAT3, STAT5A/B and STAT6 in human HCT-116 CRC cells. Moreover, STAT3 binding on genomic DNA was also investigated in HCT116 cells with NR5A2 knockdown.

2021-11-08 | E-MTAB-11113 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data